GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vectus Biosystems Ltd (ASX:VBS) » Definitions » Return-on-Tangible-Asset

Vectus Biosystems (ASX:VBS) Return-on-Tangible-Asset

: -60.13% (As of Dec. 2023)
View and export this data going back to 2016. Start your Free Trial

Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Vectus Biosystems's annualized Net Income for the quarter that ended in Dec. 2023 was A$-2.36 Mil. Vectus Biosystems's average total tangible assets for the quarter that ended in Dec. 2023 was A$3.92 Mil. Therefore, Vectus Biosystems's annualized Return-on-Tangible-Asset for the quarter that ended in Dec. 2023 was -60.13%.

The historical rank and industry rank for Vectus Biosystems's Return-on-Tangible-Asset or its related term are showing as below:

ASX:VBS' s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -818.46   Med: -117.56   Max: -54.53
Current: -54.53

During the past 8 years, Vectus Biosystems's highest Return-on-Tangible-Asset was -54.53%. The lowest was -818.46%. And the median was -117.56%.

ASX:VBS's Return-on-Tangible-Asset is ranked worse than
60.44% of 1557 companies
in the Biotechnology industry
Industry Median: -40.31 vs ASX:VBS: -54.53

Vectus Biosystems Return-on-Tangible-Asset Historical Data

The historical data trend for Vectus Biosystems's Return-on-Tangible-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vectus Biosystems Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Return-on-Tangible-Asset
Premium Member Only Premium Member Only Premium Member Only -818.46 -187.72 -94.75 -80.05 -80.53

Vectus Biosystems Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Return-on-Tangible-Asset Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -103.53 -74.67 -87.43 -50.00 -60.13

Competitive Comparison

For the Biotechnology subindustry, Vectus Biosystems's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vectus Biosystems Return-on-Tangible-Asset Distribution

For the Biotechnology industry and Healthcare sector, Vectus Biosystems's Return-on-Tangible-Asset distribution charts can be found below:

* The bar in red indicates where Vectus Biosystems's Return-on-Tangible-Asset falls into.



Vectus Biosystems Return-on-Tangible-Asset Calculation

Vectus Biosystems's annualized Return-on-Tangible-Asset for the fiscal year that ended in Jun. 2023 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(A: Jun. 2023 )  (A: Jun. 2022 )(A: Jun. 2023 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(A: Jun. 2023 )  (A: Jun. 2022 )(A: Jun. 2023 )
=-3.449/( (3.936+4.63)/ 2 )
=-3.449/4.283
=-80.53 %

Vectus Biosystems's annualized Return-on-Tangible-Asset for the quarter that ended in Dec. 2023 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(Q: Dec. 2023 )  (Q: Jun. 2023 )(Q: Dec. 2023 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(Q: Dec. 2023 )  (Q: Jun. 2023 )(Q: Dec. 2023 )
=-2.356/( (4.63+3.207)/ 2 )
=-2.356/3.9185
=-60.13 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is two times the semi-annual (Dec. 2023) net income data.


Vectus Biosystems  (ASX:VBS) Return-on-Tangible-Asset Explanation

Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.


Be Aware

Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the company’s earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a company’s tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.


Vectus Biosystems Return-on-Tangible-Asset Related Terms

Thank you for viewing the detailed overview of Vectus Biosystems's Return-on-Tangible-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Vectus Biosystems (ASX:VBS) Business Description

Traded in Other Exchanges
N/A
Address
3-11 Primrose Avenue, Rosebery, Sydney, NSW, AUS, 2018
Vectus Biosystems Ltd is an emerging biotechnology company based in Sydney, Australia. The company is in the process of developing a treatment for fibrosis and high blood pressure, which includes heart, kidney, and liver diseases. The company has also developed a technology aimed at improving the speed and accuracy of measuring the amount of DNA and RNA in samples tested in laboratories.

Vectus Biosystems (ASX:VBS) Headlines

No Headlines